Read + Share
Amedeo Smart
Independent Medical Education
Soria F, Gontero P. Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical Trial. Eur Urol 2021 Feb 4. pii: S0302-2838(21)00066.PMID: 33551296
Email
LinkedIn
Facebook
Twitter
Privacy Policy